Vol.

No.

September 07, 2018Sep 07, 2018

DOWNLOAD THE PDF

Cover Story

To “free the data,” expert group urges NCI to spend money to speed up data sharing

A working group formed by NCI Director Ned Sharpless has recommended that the institute devote additional funds informatics researchers could use to harmonize existing cancer datasets.

Free

Twitter star Vinay Prasad retires @VinayPrasadMD

By Matthew Bin Han Ong

Mendelsohn retires from MD Anderson

By Paul Goldberg

Free Obituary

Radiation oncology pioneer Moody Wharam, dies at 77

In Brief

Northwestern Lurie Cancer Center earns “exceptional” rating from NCI

Northwestern awarded brain cancer SPORE grant

Rogel Cancer Center awarded CCC designation and $33.4M from NCI

Rutgers Cancer Institute redesignated as comprehensive cancer center

Bernard Fisher turns 100

Agios announces CEO succession plan

Ruth McCorkle named AAN Living Legend

Vamsidhar Velcheti named director of thoracic medical oncology at NYU

NYU Langone's Perlmutter Cancer Center expands blood, marrow transplant program

Siteman Cancer Center expands to Illinois

ACS selects first project in “accelerator pipeline”

Smith, Thompson, Yau receive LUNGevity Career Development Awards

bluebird bio, Gritstone Oncology form collaboration to develop cancer cell therapies

JNCCN strengthens focus on original, impactful research into care delivery

Clinical Roundup

SOLAR-1 trial of Novartis meets primary endpoint in HR+/HER2- advanced breast cancer

PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA mutations

NCI-led research team develops predictor for immunotherapy response in melanoma

Cetuximab + radiation found inferior to standard treatment in HPV-positive oropharyngeal cancer

Secondhand smoke exposure in childhood may raise risk of adult lung disease

Mount Sinai researchers create RNA and DNA-sequencing platform to match broader swath of cancer drugs

Duke researchers find missing immune cells that could fight lethal brain tumors

Hopkins researchers seeking ways to monitor effectiveness of immunotherapy

Drugs & Targets

Kymriah gets European approval for B-cell ALL and diffuse large B-cell lymphoma indications

FDA gives priority review to BMS Empliciti + pomalidomide, dexamethasone in multiple myeloma

Rafael Pharmaceuticals receives FDA Orphan Drug Designation of CPI-613 for peripheral T-cell lymphoma

ASLAN003 gets Orphan Drug Designation for AML

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues